Compare NPCE & GNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NPCE | GNE |
|---|---|---|
| Founded | 1997 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Power Generation |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 432.3M | 382.1M |
| IPO Year | 2021 | 2011 |
| Metric | NPCE | GNE |
|---|---|---|
| Price | $14.60 | $14.03 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $18.33 | N/A |
| AVG Volume (30 Days) | ★ 200.5K | 46.9K |
| Earning Date | 05-12-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 2.12% |
| EPS Growth | ★ 29.03 | N/A |
| EPS | N/A | ★ 0.76 |
| Revenue | $99,986,000.00 | ★ $425,202,000.00 |
| Revenue This Year | $0.90 | $17.49 |
| Revenue Next Year | $24.46 | $7.07 |
| P/E Ratio | ★ N/A | $18.59 |
| Revenue Growth | ★ 25.13 | N/A |
| 52 Week Low | $7.56 | $13.27 |
| 52 Week High | $18.97 | $28.47 |
| Indicator | NPCE | GNE |
|---|---|---|
| Relative Strength Index (RSI) | 56.94 | 50.19 |
| Support Level | $14.02 | $13.53 |
| Resistance Level | $14.72 | $14.87 |
| Average True Range (ATR) | 0.67 | 0.56 |
| MACD | 0.18 | 0.02 |
| Stochastic Oscillator | 84.06 | 45.00 |
NeuroPace Inc is a medical device company focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of seizures. The company offers the RNS System, a brain-responsive neuromodulation system that continuously monitors and analyzes the brain's electrical activity and delivers personalized, real-time electrical pulses at the seizure source to prevent seizures. The RNS System includes the RNS neurostimulator, cortical strip leads, depth leads, a Patient Remote Monitor, and other implantable and non-implantable accessories used during implant procedures. The company also provides the Physician Tablet, Patient Data Management System, and the nSight Platform to facilitate ongoing patient monitoring and support clinicians in managing patient care.
Genie Energy Ltd, through its subsidiaries, operates as a retail energy provider. It serves two reportable business segments: Genie retail energy, or GRE, and Genie renewables. The Genie retail energy segment resells energy to residential and commercial consumers in the Eastern and Midwestern United States through its portfolio of various retail energy providers. The Genie renewables segment holds controlling interests in various companies engaged in the manufacturing of solar panels, solar installation design, and solar energy project management. It generates the majority of its revenue from the Genie retail energy segment.